Advertisement
JYNT vs SRTA
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JYNT is a Hold and SRTA is a Buy.
JYNT in -9.77% downward trend, falling for three consecutive days on November 09, 2026
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where JYNT declined for three days, in 268 of 328 cases, the price declined further within the following month. The odds of a continued downward trend are 82%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on November 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on JYNT as a result. In 81 of 107 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 76%.
The Moving Average Convergence Divergence Histogram (MACD) for JYNT turned negative on November 09, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 41 similar instances when the indicator turned negative. In 33 of the 41 cases the stock turned lower in the days that followed. This puts the odds of success at 80%.
The Aroon Indicator for JYNT entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where JYNT's RSI Indicator exited the oversold zone, 32 of 38 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 84%.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
Following a +2.01% 3-day Advance, the price is estimated to grow further. Considering data from situations where JYNT advanced for three days, in 158 of 235 cases, the price rose further within the following month. The odds of a continued upward trend are 67%.
JYNT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 48 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 70 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.112) is normal, around the industry mean (204.532). P/E Ratio (26.346) is within average values for comparable stocks, (21.572). Projected Growth (PEG Ratio) (0.140) is also within normal values, averaging (2.498). Dividend Yield (0.000) settles around the average of (0.154) among similar stocks. P/S Ratio (2.154) is also within normal values, averaging (2.688).
The Tickeron Price Growth Rating for this company is 72 (best 1 - 100 worst), indicating slightly worse than average price growth. JYNT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 96 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. JYNT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
SRTA in upward trend: price rose above 50-day moving average on November 04, 2026
SRTA moved above its 50-day moving average on November 04, 2026 date and that indicates a change from a downward trend to an upward trend. In 35 of 38 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on November 04, 2026. You may want to consider a long position or call options on SRTA as a result. In 61 of 74 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 82%.
The Moving Average Convergence Divergence (MACD) for SRTA just turned positive on October 20, 2026. Looking at past instances where SRTA's MACD turned positive, the stock continued to rise in 43 of 49 cases over the following month. The odds of a continued upward trend are 88%.
The 10-day moving average for SRTA crossed bullishly above the 50-day moving average on November 10, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 19 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
Following a +15.02% 3-day Advance, the price is estimated to grow further. Considering data from situations where SRTA advanced for three days, in 203 of 250 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
Bearish Trend Analysis
The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The 50-day moving average for SRTA moved below the 200-day moving average on November 02, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SRTA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.
SRTA broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for SRTA entered a downward trend on October 26, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Seasonality Score of 5 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 32 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 38 (best 1 - 100 worst), indicating steady price growth. SRTA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 54 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 57 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.761) is normal, around the industry mean (204.532). P/E Ratio (11.347) is within average values for comparable stocks, (21.572). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.498). Dividend Yield (0.000) settles around the average of (0.154) among similar stocks. P/S Ratio (1.730) is also within normal values, averaging (2.688).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SRTA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
JYNT | SRTA | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 8 | 41 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 70 Overvalued | 57 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 48 | 54 | |
PRICE GROWTH RATING 1..100 | 72 | 38 | |
P/E GROWTH RATING 1..100 | 96 | 32 | |
SEASONALITY SCORE 1..100 | 50 | 5 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
SRTA's Valuation (57) in the null industry is in the same range as JYNT (70) in the Hospital Or Nursing Management industry. This means that SRTA’s stock grew similarly to JYNT’s over the last 12 months.
SRTA's Profit vs Risk Rating (100) in the null industry is in the same range as JYNT (100) in the Hospital Or Nursing Management industry. This means that SRTA’s stock grew similarly to JYNT’s over the last 12 months.
JYNT's SMR Rating (48) in the Hospital Or Nursing Management industry is in the same range as SRTA (54) in the null industry. This means that JYNT’s stock grew similarly to SRTA’s over the last 12 months.
SRTA's Price Growth Rating (38) in the null industry is somewhat better than the same rating for JYNT (72) in the Hospital Or Nursing Management industry. This means that SRTA’s stock grew somewhat faster than JYNT’s over the last 12 months.
SRTA's P/E Growth Rating (32) in the null industry is somewhat better than the same rating for JYNT (96) in the Hospital Or Nursing Management industry. This means that SRTA’s stock grew somewhat faster than JYNT’s over the last 12 months.
| JYNT | SRTA | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 84% | 2 days ago 86% |
| Stochastic ODDS (%) | 2 days ago 82% | 2 days ago 84% |
| Momentum ODDS (%) | 2 days ago 76% | 2 days ago 82% |
| MACD ODDS (%) | 2 days ago 80% | 2 days ago 88% |
| TrendWeek ODDS (%) | 2 days ago 81% | 2 days ago 84% |
| TrendMonth ODDS (%) | 2 days ago 80% | 2 days ago 82% |
| Advances ODDS (%) | 14 days ago 67% | 3 days ago 81% |
| Declines ODDS (%) | 3 days ago 82% | 10 days ago 85% |
| BollingerBands ODDS (%) | 2 days ago 79% | 2 days ago 86% |
| Aroon ODDS (%) | 2 days ago 78% | 2 days ago 76% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
JYNT’s FA Score shows that 0 FA rating(s) are green while SRTA’s FA Score has 1 green FA rating(s).
- JYNT’s FA Score: 0 green, 5 red.
- SRTA’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
JYNT’s TA Score shows that 4 TA indicator(s) are bullish while SRTA’s TA Score has 5 bullish TA indicator(s).
- JYNT’s TA Score: 4 bullish, 4 bearish.
- SRTA’s TA Score: 5 bullish, 6 bearish.
Price Growth
JYNT (@Hospital/Nursing Management) experienced а -5.14% price change this week, while SRTA (@Hospital/Nursing Management) price change was +35.59% for the same time period.
The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was -5.75%. For the same industry, the average monthly price growth was +0.37%, and the average quarterly price growth was +10.84%.
Reported Earning Dates
JYNT is expected to report earnings on Mar 11, 2027.
SRTA is expected to report earnings on Mar 16, 2027.
Industries' Descriptions
@Hospital/Nursing Management (-5.75% weekly)Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.
Advertisement
JYNT and
Correlation & Price change
A.I.dvisor tells us that JYNT and ADUS have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that JYNT and ADUS's prices will move in lockstep.
| Ticker / NAME | Correlation To JYNT | 1D Price Change % | ||
|---|---|---|---|---|
| JYNT | 100% | +2.71% | ||
| ADUS - JYNT | 29% Poorly correlated | +3.16% | ||
| CON - JYNT | 28% Poorly correlated | +0.64% | ||
| BTMD - JYNT | 25% Poorly correlated | -2.70% | ||
| INNV - JYNT | 25% Poorly correlated | +1.74% | ||
| PIII - JYNT | 23% Poorly correlated | -20.47% | ||
More | ||||
SRTA and
Correlation & Price change
A.I.dvisor indicates that over the last year, SRTA has been loosely correlated with JOBY. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if SRTA jumps, then JOBY could also see price increases.
| Ticker / NAME | Correlation To SRTA | 1D Price Change % | ||
|---|---|---|---|---|
| SRTA | 100% | -0.50% | ||
| JOBY - SRTA | 57% Loosely correlated | -4.21% | ||
| UP - SRTA | 36% Loosely correlated | -10.87% | ||
| AIRS - SRTA | 25% Poorly correlated | +14.11% | ||
| JYNT - SRTA | 24% Poorly correlated | +2.71% | ||
| STLN - SRTA | 24% Poorly correlated | +8.50% | ||
More | ||||